Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1: a comparison with infliximab treatment.

Di Paola R, Genovese T, Impellizzeri D, Ahmad A, Cuzzocrea S, Esposito E.

Eur J Pharmacol. 2013 Jan 30;700(1-3):134-46. doi: 10.1016/j.ejphar.2012.11.066. Epub 2013 Jan 3.

PMID:
23291313
2.

Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.

Di Paola R, Impellizzeri D, Mondello P, Velardi E, Aloisi C, Cappellani A, Esposito E, Cuzzocrea S.

Shock. 2012 Oct;38(4):356-66.

PMID:
22772472
3.

Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.

Patel NS, Chatterjee PK, Di Paola R, Mazzon E, Britti D, De Sarro A, Cuzzocrea S, Thiemermann C.

J Pharmacol Exp Ther. 2005 Mar;312(3):1170-8. Epub 2004 Nov 30.

4.

Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha.

Esposito E, Mazzon E, Muià C, Meli R, Sessa E, Cuzzocrea S.

J Leukoc Biol. 2007 Apr;81(4):1032-43. Epub 2007 Jan 8.

PMID:
17210619
5.

Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept.

Mazzon E, Esposito E, Di Paola R, Muià C, Crisafulli C, Genovese T, Caminiti R, Meli R, Bramanti P, Cuzzocrea S.

Clin Exp Immunol. 2008 Jul;153(1):136-49. doi: 10.1111/j.1365-2249.2008.03669.x. Epub 2008 May 26.

6.

Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.

Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C.

Kidney Int. 2000 Aug;58(2):658-73.

7.

Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats.

Esposito E, Mondello S, Di Paola R, Mazzon E, Italiano D, Paterniti I, Mondello P, Aloisi C, Cuzzocrea S.

Naunyn Schmiedebergs Arch Pharmacol. 2011 May;383(5):493-508. doi: 10.1007/s00210-011-0610-5. Epub 2011 Mar 11.

PMID:
21394482
8.

Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-κB pathway in ischemia/reperfusion-induced acute kidney injury.

Lee JW, Kim SC, Ko YS, Lee HY, Cho E, Kim MG, Jo SK, Cho WY, Kim HK.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):121-7. doi: 10.1016/j.bbrc.2014.01.005. Epub 2014 Jan 14.

PMID:
24434153
9.

The protective effect of oxytocin on renal ischemia/reperfusion injury in rats.

Tuğtepe H, Sener G, Biyikli NK, Yüksel M, Cetinel S, Gedik N, Yeğen BC.

Regul Pept. 2007 May 3;140(3):101-8. Epub 2007 Jan 29.

PMID:
17261335
10.

GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury.

Chatterjee PK, Patel NS, Sivarajah A, Kvale EO, Dugo L, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, Yaqoob MM, Thiemermann C.

Kidney Int. 2003 Mar;63(3):853-65.

11.

Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury.

Venkatachalam K, Prabhu SD, Reddy VS, Boylston WH, Valente AJ, Chandrasekar B.

J Biol Chem. 2009 Mar 20;284(12):7853-65. doi: 10.1074/jbc.M808824200. Epub 2009 Jan 21.

12.

Montelukast protects against renal ischemia/reperfusion injury in rats.

Sener G, Sehirli O, Velioğlu-Oğünç A, Cetinel S, Gedik N, Caner M, Sakarcan A, Yeğen BC.

Pharmacol Res. 2006 Jul;54(1):65-71. Epub 2006 Mar 2.

PMID:
16584888
13.

Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats.

Dulundu E, Ozel Y, Topaloglu U, Sehirli O, Ercan F, Gedik N, Sener G.

Pharmacology. 2007;79(3):163-70. Epub 2007 Jan 24.

PMID:
17259747
14.

Protective effect of infliximab on ischemia/reperfusion-induced damage in rat kidney.

Tasdemir C, Tasdemir S, Vardi N, Ates B, Parlakpinar H, Kati B, Karaaslan MG, Acet A.

Ren Fail. 2012;34(9):1144-9. doi: 10.3109/0886022X.2012.717490. Epub 2012 Sep 6.

PMID:
22950848
15.

The effect of phlebotomy and mannitol on acute renal injury induced by ischemia/reperfusion of lower limbs in rats.

Goksin I, Adali F, Enli Y, Akbulut M, Teke Z, Sackan G, Ocak E, Ozcan AV.

Ann Vasc Surg. 2011 Nov;25(8):1118-28. doi: 10.1016/j.avsg.2011.07.007.

PMID:
22023943
16.

Effects of trapidil on renal ischemia-reperfusion injury.

Avlan D, Tamer L, Ayaz L, Polat A, Oztürk C, Ozturhan H, Camdeviren H, Aksöyek S.

J Pediatr Surg. 2006 Oct;41(10):1686-93.

PMID:
17011270
17.

Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages.

Crisafulli C, Galuppo M, Cuzzocrea S.

Pharmacol Res. 2009 Oct;60(4):332-40. doi: 10.1016/j.phrs.2009.05.001. Epub 2009 May 18.

PMID:
19450684
18.

Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury.

Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, De Sarro A, Van de Loo FA, Caputi AP, Thiemermann C.

Shock. 2002 Aug;18(2):169-76.

PMID:
12166782
19.

Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury.

Chen HH, Chen TW, Lin H.

Am J Physiol Renal Physiol. 2009 Oct;297(4):F1109-18. doi: 10.1152/ajprenal.00057.2009. Epub 2009 Jul 29.

20.

Combination of tadalafil and diltiazem attenuates renal ischemia reperfusion-induced acute renal failure in rats.

El-Sisi AE, Sokar SS, Abu-Risha SE, Ibrahim HA.

Biomed Pharmacother. 2016 Dec;84:861-869. doi: 10.1016/j.biopha.2016.10.009. Epub 2016 Oct 11.

PMID:
27736652

Supplemental Content

Support Center